Si-Bone SEC Filings

RLH Capital LLC and managing member Louis Camhi filed Amendment No. 1 to Schedule 13G disclosing a passive holding of 295,400 Class A ordinary shares of Eureka Acquisition Corp (EURKU) as of 30 June 2025.

The reporting persons possess shared voting and dispositive power over 100 % of the reported shares and no sole authority. The position equals 9.3 % of the outstanding Class A float, crossing the 5 % disclosure threshold yet remaining below the 10 % level that would typically trigger a Schedule 13D for control-oriented investors.

RLH Capital, classified as an investment adviser (IA) under Rule 13d-1(b)(1)(ii)(E), certifies the stake was accumulated in the ordinary course of business and not to influence management or corporate control. No group arrangements, subsidiaries, or additional beneficiaries are identified, and there are no related transactions or derivative positions described.

For shareholders, the filing highlights the presence of a mid-sized institutional investor holding nearly a tenth of the SPAC’s equity. This may improve float stability and market awareness but does not signal imminent strategic or activist activity.

SI-BONE, Inc. (SIBN) – Form 4 insider transaction

Anthony J. Recupero, President of Commercial Operations, disclosed two same-day open-market sales tied to a tax-withholding, “sell-to-cover” arrangement related to vested restricted stock units (RSUs).

• Date: 07/02/2025
• Shares sold: 1,556 at a weighted average price of $18.2802 and 1,754 at $18.2622, totaling 3,310 shares.
• Price ranges: $18.065–18.43 and $18.12–18.42 (per footnotes).
• Purpose: Mandatory sale to satisfy payroll-tax obligations; not a discretionary trade (Footnote 1).
• Post-sale ownership: 279,121 common shares, of which 155,797 are underlying RSUs.

The filing reflects routine tax-related insider activity representing roughly 1.2% of Recupero’s reported holdings, leaving a substantial ownership stake intact.

SI-BONE, Inc. (SIBN) – Form 4 filing dated 07/07/2025

Senior Vice President, Operations & Administration and Chief Legal Officer Michael A. Pisetsky reported a routine “sell-to-cover” transaction tied to the vesting of restricted stock units (RSUs) on 07/02/2025. To satisfy withholding taxes, Pisetsky sold an aggregate 3,127 common shares in three market transactions at weighted-average prices between $18.26 – $18.38 per share.

Following the sales, the executive retains 261,681 common shares, which includes 145,043 shares underlying un-settled RSUs. No derivative securities were involved, and the filing states the sales were non-discretionary and solely for tax purposes.

The disposition represents approximately 1.2 % of the executive’s post-transaction holdings and does not alter overall insider ownership meaningfully. There is no indication of strategic intent or change in outlook for SIBN; the filing is considered administratively routine under Section 16 rules.

Nature's Sunshine Products, Inc. (NATR) – Form 144 filing overview

Richard D. Moss, acting through his Revocable Trust, has filed a Form 144 indicating an intent to sell 3,500 shares of NATR common stock. The proposed sale will be executed through Wells Fargo Clearing Services on or about 07 July 2025. At the filing date, the shares carry an aggregate market value of $54,986.51, implying a reference price of roughly $15.71 per share. The company reports 18,350,801 shares outstanding, so the prospective transaction represents approximately 0.02 % of the float.

Acquisition background

• The 3,500 shares were acquired on 06 May 2024 through restricted-stock grants and compensation issued by the company.

Prior insider activity (last 3 months)

• The same filer and related entities have already sold 42,734 shares between 09 May 2025 and 03 July 2025.
• Cumulative gross proceeds from those sales total ≈ $620,000 (per individual line items in the filing).

Key takeaways for investors

• The filing signals the insider’s intention to continue reducing exposure after a series of sizable disposals.
• Although the upcoming block is small relative to total shares outstanding, persistent insider selling can be interpreted by the market as a potential negative sentiment indicator.

SI-BONE, Inc. (SIBN) has filed a Form 144 disclosing a proposed insider sale of common stock.

The notice covers the planned disposition of 1,695 shares at an aggregate market value of $31,238.85. The transaction is scheduled for on or about 07/03/2025 and will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. According to the filing, SI-BONE has 42,614,514 shares outstanding, so the upcoming sale represents less than 0.01% of the float.

The securities being sold were acquired on 07/01/2025 via restricted stock units issued by the company. Payment details are listed as “N/A,” indicating no cash consideration was required at acquisition.

Recent trading activity by the same account is also disclosed. Over the past three months, the filer completed six sales totaling 50,233 shares for approximately $929,583 in gross proceeds. Five of those trades were executed under a Rule 10b5-1 trading plan.

• Shares to be sold: 1,695
• Approximate value: $31,238.85
• Broker: Morgan Stanley Smith Barney LLC, New York
• Outstanding shares: 42,614,514
• Prior 3-month insider sales: 50,233 shares / $929,582.89

The signer of the notice certifies that no undisclosed material adverse information is known and that the trade complies with Rule 10b5-1, underscoring procedural adherence. Given the very small percentage of shares involved, the immediate financial impact appears limited, though the continued pattern of insider selling may draw investor attention.